Amgen shows prevailing Real Value of $166.91625 per share. The current price of the firm is $176.3. At this time the firm appears to be over valued. Macroaxis approximates value of Amgen from analyzing the firm fundamentals such as Profit Margin of
9.67% and Return On Equity of 9.59% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|